Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Consensus of the Brazilian Society of Infectious Diseases and Brazilian Society of Clinical Oncology on the management and treatment of Kaposi's sarcoma.
Arruda É, Jacome AA, Toscano AL, Silvestrini AA, Rêgo AS, Wiermann EG, Cunha GF Jr, Melo HR, Morejón KM, Goldani LZ, Pereira LC Jr, Silva MH, Treistman MS, Pereira MC, Romero PM, Schmerling RA, Guedes RA, Camargo VP. Arruda É, et al. Among authors: camargo vp. Braz J Infect Dis. 2014 May-Jun;18(3):315-26. doi: 10.1016/j.bjid.2014.01.002. Epub 2014 Feb 11. Braz J Infect Dis. 2014. PMID: 24525061 Free PMC article.
Systemic dissemination of glioblastoma: literature review.
Carvalho JADV, Barbosa CCL, Feher O, Maldaun MVC, Camargo VP, Moraes FY, Marta GN. Carvalho JADV, et al. Among authors: camargo vp. Rev Assoc Med Bras (1992). 2019 Mar;65(3):460-468. doi: 10.1590/1806-9282.65.3.460. Epub 2019 Apr 11. Rev Assoc Med Bras (1992). 2019. PMID: 30994848 Free article. Review.
Treatment of advanced melanoma - A changing landscape.
Hepner A, Salgues A, Anjos CAD, Sahade M, Camargo VP, Garicochea B, Shoushtari AN, Postow MA, Fernandes GS, Munhoz RR. Hepner A, et al. Among authors: camargo vp. Rev Assoc Med Bras (1992). 2017 Sep;63(9):814-823. doi: 10.1590/1806-9282.63.09.814. Rev Assoc Med Bras (1992). 2017. PMID: 29239458 Free article. Review.
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial.
Schöffski P, Chawla S, Maki RG, Italiano A, Gelderblom H, Choy E, Grignani G, Camargo V, Bauer S, Rha SY, Blay JY, Hohenberger P, D'Adamo D, Guo M, Chmielowski B, Le Cesne A, Demetri GD, Patel SR. Schöffski P, et al. Lancet. 2016 Apr 16;387(10028):1629-37. doi: 10.1016/S0140-6736(15)01283-0. Epub 2016 Feb 10. Lancet. 2016. PMID: 26874885 Free article. Clinical Trial.
Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial.
Guo J, Carvajal RD, Dummer R, Hauschild A, Daud A, Bastian BC, Markovic SN, Queirolo P, Arance A, Berking C, Camargo V, Herchenhorn D, Petrella TM, Schadendorf D, Sharfman W, Testori A, Novick S, Hertle S, Nourry C, Chen Q, Hodi FS. Guo J, et al. Ann Oncol. 2017 Jun 1;28(6):1380-1387. doi: 10.1093/annonc/mdx079. Ann Oncol. 2017. PMID: 28327988 Free PMC article. Clinical Trial.
A phase 2 study of first-line nivolumab in patients with locally advanced or metastatic cutaneous squamous-cell carcinoma.
Munhoz RR, Nader-Marta G, de Camargo VP, Queiroz MM, Cury-Martins J, Ricci H, de Mattos MR, de Menezes TAF, Machado GUC, Bertolli E, Barros M, de Souza CE, Franke F, Ferreira FO, Feher O, de Castro G Jr. Munhoz RR, et al. Among authors: de camargo vp. Cancer. 2022 Dec 15;128(24):4223-4231. doi: 10.1002/cncr.34463. Epub 2022 Oct 24. Cancer. 2022. PMID: 36274573 Free article. Clinical Trial.
16 results